lifestyle.militaryparenting.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
IN8bio, Inc
IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
May 14, 2026
IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 7, 2026
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
May 6, 2026
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 3, 2026
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results – Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
March 12, 2026